David Young - Pres. Research & Development, Director at Processa Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. Research & Development, Director
Issuer Symbol
PCSA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Young since 05 Jan 2025

Holdings reported by David Young for Processa Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 217,332 $45,639 $0.2100 24 Jul 2025 Direct
Restricted Stock Units 111,000 $43,015 $1.71 01 Oct 2025 Direct Common Stock
Common Stock 30,985 $6,506 $0.2100 24 Jul 2025 By Young-Plaisance Revocable Trust
Common Stock 18,544 $3,894 $0.2100 24 Jul 2025 By CorLyst, LLC
Common Stock 10,786 $2,265 $0.2100 24 Jul 2025 By Family Entities
Stock Options (Right to Buy) 333,000 01 Oct 2025 Direct Common Stock
Warrants 62,250 29 Jan 2025 Direct Common Stock

Transactions reported by David Young for Processa Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.